SK bioscience Co.,Ltd. (KRX:302440)
South Korea · Delayed Price · Currency is KRW 37,650
+800 (2.17%)
At close: Aug 14, 2026
SK bioscience Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, SK bioscience stock has a consensus rating of "Sell" and an average price target of ₩32,500. The average 1-year stock price forecast is 13.68% lower than the current stock price, while the lowest is ₩25,000 (-33.60%) and the highest is ₩46,000 (+22.18%).
Price Target: ₩32,500 (-13.68%)
Analyst Consensus: Sell
Price Target
ChartAnalyst Ratings
The average analyst rating for SK bioscience stock is "Sell". This means that analysts believe this stock is likely to lead to lower returns than market as a whole.
Recommendation Trends
| Rating | Nov '25 | Jan '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 3 | 2 | 2 | 1 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 2 | 2 | 2 | 2 | 2 | 2 |
| Total | 6 | 6 | 6 | 5 | 5 | 4 |
Financial Forecast
Revenue This Year
687.50B
from 651.37B
Increased by 5.55%
Revenue Next Year
753.46B
from 687.50B
Increased by 9.59%
EPS This Year
-1.32K
from -733.00
EPS Next Year
-966.62
from -1.32K
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is KRW.